Dr. Susan Horling, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 33155 Annapolis St, Emergency Medicine Department, Wayne, MI 48184 Phone: 734-467-4042 |
Dr. Gregory Golicz, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 37625 Michigan Ave, Fmc-wayne Medical Dept, Wayne, MI 48184 Phone: 734-467-0222 Fax: 734-467-0973 |
Nouh Mazloum, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 33155 Annapolis St, Wayne, MI 48184 Phone: 734-467-4000 |
Dr. Sarah Cecelia Flynn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 33155 Annapolis St, Emergency Medicine Department, Wayne, MI 48184 Phone: 734-467-4042 Fax: 734-467-5500 |
Sharon R. Sneed, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 33155 Annapolis St, Emergency Department, Wayne, MI 48184 Phone: 734-467-4042 Fax: 734-467-5500 |
Dr. Heather E Rice, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 33155 Annapolis, Wayne, MI 48184 Phone: 734-467-4042 Fax: 734-467-5500 |
Sami Hassen Hammoud, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 33155 Annapolis St, Wayne, MI 48184 Phone: 734-467-4000 |
News Archive
Researchers from University Hospitals Case Medical Center's Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials.
Thirteen pharmaceutical companies; the governments of the U.S., U.K. and United Arab Emirates; the Bill & Melinda Gates Foundation; the WHO; the World Bank; the Drugs for Neglected Diseases initiative (DNDi); and other global health organizations "announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade," according to a press release from Global Health Strategies.
Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.
A study published by The Burnham Institute in the September edition of Molecular Cell reports that a cell-cycle checkpoint protein, known to be activated by an important class of anticancer drugs, may play crucial roles in both the hampering of therapeutic actions and aiding cancer cells to "recover" and start dividing again after treatment with these drugs.
› Verified 6 days ago